======= script was here =======


Droctor Eugene D. Kaplan, MD - Neurology, Pain management, Stroke, Headache Secialist
Dr. Eugene D. Kaplan is a diplomat of the Board of American Academy of Psychiatry and Neurology, American Board of Interventional Pain Physicians, Board of Headache Medicine, Board of Vascular Neurology and a Fellow of Interventional Pain Physicians. As pain is a function of the Central Nervous System, dual expertise in Neurology and Pain Management creates a comprehensive approach to the patient. 



Dr. Eugene D. Kaplan is a President and a Medical Director of Neurological and Stroke Care, PLLC and a Medical Director of Comprehensive Pain Management Center and Headache and Facial Pain Treatment Center divisions serving patients in Albany and the Capital Region.


He originally graduated from Kuibyshev Medical School in Samara, Russia as a general surgeon with a consequent sub-specialization in intensive care and anesthesia. He moved to the United States in 1993 with a 10 year experience working in the areas of his expertise. His medical positions included an Attending Physician in the Intensive Care Unit at the Regional Toxicology Center, Attending Physician in a Hyperbarooxygenotherapy Department, Attending Physician and Chief of the Intensive Care Department at a Cardio-Pulmonary hospital. In spite of his multiple responsibilities he was also teaching in the Nursing Education Program and teaching and supervising of medical students.


Upon his arrival to the US he first did his training at the Neurology Residency Program at Albany Medical Center. He was awarded the “Excellence in Neurological Physical Examination” Award at the Residency Program in 1999. During his senior year he served as a Chief Resident and a Journal Club Leader. After graduation from the Residency Program he completed a two year fellowship at Columbia University where he also worked as an attending physician at a Stroke Center in addition to being a Post-Doctoral Epidemiology Fellow and Post-Doctoral Research Fellow. He was actively involved in teaching and supervision of Neurology Residents. During his fellowship years he also earned a combined double degree of Master in Public Health from Columbia University – one in “Epidemiology and Clinical Research” and another in “Health Care Policy and Management”.


Dr. Kaplan has always been involved in medical research. Being a medical student, he started investigating new organic compounds for carcinogenic activity as a research technician at the Toxicology Research Laboratory, Kuibyshev Medical Institute, Kuibyshev, Russia. He soon co-founded an Experimental Oncology Interdisciplinary Research Group at the Department of Pathophysiology, Kuibyshev Medical Institute, Kuibyshev, Russia. As a fellow at the Columbia University, Dr. Eugene Kaplan participated in the North Manhattan Stroke Study (NOMASS) as a Research Fellow. The results of his research were presented at Neurological and Stroke meetings in the USA and Europe.


At Columbia-Presbyterian Medical Center he was also a co-investigator in clinical trials, including Aortic Plaque in Stroke Study (APRIS), Multi-Ethnic Study of Atherosclerosis (MESA), Hemicraniectomy and Durotomy for Deterioration From Infarction Relating Swelling Trial (HeaDDFIRST) Study, ARGatroban Injection in patients with acute ischemic Stroke (ARGIS-1) Study, Management of Atherothrombosis with Clopidogrel in High-risk patients with recent TIA or ischemic stroke (MATCH) Study and AMPA Receptor Antagonist Treatment in Ischemic Stroke Trial (ARTIST) Study. He was also the principle investigator for the Stroke Educational Program Impact Study (SEPIS), St. Clare’s Hospital, Schenectady, NY.


Dr. Kaplan is a member of many professional societies:

  • American Academy of Neurology
  • American Headache Society
  • American Neuromodulation Society
  • American Society of Interventional Pain Physicians
  • American Society of Regional Anesthesia
  • American Society of Neuroimaging
  • American Stroke Association
  • Epilepsy Foundation
  • International Spine Intervention Society
  • Restless Legs Syndrome Foundation
  • World Institute of Pain

Dr. Kaplan is an editor on Editorial Board of “Pain Physician” journal. He served as a reviewer of manuscripts for the American Heart Association “Stroke” journal. Dr. Kaplan is a member of the Professional Advisory Board of Epilepsy Foundation of Upstate New York. He is also a member of the Interventional Headache Treatment Group of American Headache Society and of the Stroke Council of American Stroke Association.


Dr. Eugene Kaplan is the author and co-author of numerous medical publications, including:

  1. Kaplan E.D. Association between Homocysteine Levels and Risk of Vascular Events. Review. Timely topics in Medicine Barcelona. March 2003.
  2. Kaplan E.D., Sacco R.L. Use of Antiplatelet Therapy for Stroke Prevention. Clinical Geriatrics 2002, 10:2; p55-62.
  3. Kaplan E.D., Sacco R.L. Selection of Anticoagulants or Antiplatelet-aggregating Agents for Prevention of Stroke. Current Neurology and Neuroscience Reports 2002, 2:1, p31-37.
  4. Kaplan E.D., Pittman J.G., Elkind M.S., Boden-Albala B., Stabler S.P., Sacco R.L. Stroke Risk Factor Subgroups, Vascular Events and Homocysteine: The Northern Manhattan Cohort Study. Abstract. 11th European Stroke Conference. Geneva, Switzerland. Cerebrovascular Diseases 2002, 13:Suppl 3; p90.
  5. Kaplan E.D., Pittman J.G., Elkind M.S., Boden-Albala B., Wright C.B., Rundek T.S., Stabler S.P., Sacco R.L. Homocysteine is Associated With Increased Vascular Morbidity and Mortality: the Northern Manhattan Prospective Cohort Study. Abstract. 54th American Academy of Neurology Meeting Denver, CO. Neurology 2002, 58:7(Suppl 3); pA98.
  6. Wright C.B., Rundek T.S., Pittman J.G., Boden-Albala B., Kaplan E.D., Sacco R.L. A Cross-Sectional Analysis of Vascular Risk Factors and Cognitive Status in a Multiethnic Elderly Population. Abstract. 54th American Academy of Neurology Meeting Denver, CO. Neurology 2002, 58:7(Suppl 3); pA113.
  7. Rundek T.S., Elkind M.S., Pittman J.G., Wright C.B., Boden-Albala B., Kaplan E.D., Sacco R.L. Carotid Artery Plaque Thickness Predicts Ischemic Stroke, Myocardial Infarction, and Vascular Death: the Northern Manhattan Prospective Cohort Study. Abstract. 54th American Academy of Neurology Meeting Denver, CO. Neurology 2002, 58:7(Suppl 3); pA118.
  8. Kaplan E.D., Boden-Albala B., Rundek T.S., Elkind M.S., Sacco R.L. Blood Levels of Vitamin B12 and Folate are Associated with Carotid Artery Plaque Thickness: The Northern Manhattan Stroke Study. Abstract. 27th International Stroke Meeting. 2002. Stroke. 2002. 33:1; p390.
  9. Rundek T., Elkind M.S., Pittman J, Wright C.B., Seung-Han Suk, Kaplan E.D., Boden-Albala B., Stabler S.P., Sacco R.L. Carotid Artery Diameter and Stiffness in a Population of Elderly Women and Men: The Northern Manhattan Stroke Study. Abstract. 27th International Stroke Meeting. Stroke. 2002. 33:1; p370.
  10. Kaplan E.D., Cheng J, Boden-Albala B., Rundek T.S., Elkind M.S., Sacco R.L. Homocysteine Is Associated With Carotid Artery Plaque Thickness: The Northern Manhattan Stroke Study. Abstract. 53rd American Academy of Neurology Meeting. 2001. Philadelphia, PA.
  11. Nizovtsev V.P., Ginsburg M.M., Kaplan E.D., Kramnic I.B.. Embryonal antigens of Erlich ascitic tumor. In: New approaches in oncology and medicine. P 49-50. Kuibyshev, 1982.
  12. Nizovtsev V.P., Ginsburg M.M., Kaplan E.D., Kramnic I.B. Embryonic regulators promote adaptation of tumor cells to growth-controlling systems of an organism. In: Conference proceedings: Issues of adaptation, compensation and rehabilitation in pathologic conditions, p. 118-119. Kuibyshev, 1982.
  13. Nizovtsev V.P., Ginsburg M.M., Kramnic I.B., Kaplan E. D. Adaptation of Gelshtein ascitic hepatoma 22a to growth in not bred mice. In: Conference proceedings: Issues of adaptation, compensation and rehabilitation in pathologic conditions, p 119-120. Kuibyshev, 1982.


Dr. Eugene Kaplan is a holder of two patents for his medical inventions:

  1. Kaplan ED, Ginsburg MM, Kramnic IB. “MPB-2 optic set utilization in studying of small laboratory animals embryos.” Registered #37/83 on 1/25/83, Kuibyshev Medical Institute. Kuibyshev, Russia.
  2. Kaplan ED, Tseitlin DM, Nizovtsev VP. “Syringe add-on”. Registered #147a/81 on 10/27/81, Kuibyshev Medical Institute. Kuibyshev, Russia.


Dr. Kaplan has been active in medical education. He served as a Neurological Education Coordinator at the Family Practice Residency Program at St. Clare’s Hospital in Schenectady, NY. He presented lectures on various medical topics including:

  1. Interventional Pain Management. Grand Rounds. St. Clare’s Hosp. Schenectady, NY. December, 2007.
  2. Antiplatelet Use in the Secondary Stroke Prevention. Schenectady, NY. November, 2007.
  3. Transcranial Doppler. Grand Rounds. Ellis Hospital. Schenectady, NY. October, 2007.
  4. New Developments in the Diagnosis and Treatment of Migraine Headache. Grand Rounds. St. Clare’s Hospital. Schenectady, NY. September, 2007.
  5. Antiplatelet Use in the Secondary Stroke Prevention. Glen Falls, NY. April, 2007.
  6. New Developments in the Diagnosis and Treatment of Migraine Headache. Grand Rounds. St. Clare’s Hospital. Schenectady, NY. June 28, 2005.
  7. Antiplatelet Use in the Secondary Stroke Prevention. Schenectady, NY. June 2, 2005.
  8. Secondary Stroke Prevention. Grand Rounds. St. Clare’s Hospital. Schenectady, NY. May 31, 2005.
  9. Diagnosis and Treatment of Dementia. Grand Rounds. St. Clare’s Hospital. Schenectady, NY. May 10, 2005.
  10. Antiplatelets Use in the Secondary Stroke Prevention. April 28, 2004. Saratoga Springs, NY
  11. Antiplatelets Use in the Secondary Stroke Prevention. April 8, 2004. Port Henry, NY
  12. Acute Stroke: Treatment Approaches and Diagnostic Modalities. The Role of Transcranial Doppler. Grand Rounds. St. Clare’s Hospital. February 23, 2003. Schenectady, NY.
  13. Diagnosis and Treatment of Early Stroke: 2003 American Heart Association Guidelines. Grand Rounds. St. Clare’s Hospital. December 23, 2003. Schenectady, NY.
  14. Diagnosis and Treatment of Dementia. Grand Rounds. Little Falls Hospital. Little Falls, NY. June 2003.
  15. Neurological Assessment and Treatment of Cerebrovascular Diseases. Four-Hour Teaching Course for Nurses and Physician Assistants. St. Clare’s Hospital. Schenectady, NY. February 2003.
  16. Neurological Assessment and Treatment of Cerebrovascular Diseases. Four-Hour Teaching Course for Nurses and Physician Assistants. St. Clare’s Hospital. January 2003.
  17. Stroke Assessment and Treatment. Two-Hour Presentation for EMS. Schenectady, NY. December 2002.
  18. Neurological Assessment and Treatment of Cerebrovascular Diseases. Four-Hour Teaching Course for Nurses and Physician Assistants. St. Clare’s Hospital. Schenectady, NY. December 2002.
  19. Neurological Assessment and Treatment of Cerebrovascular Diseases. Four-Hour Teaching Course for Nurses and Physician Assistants. St. Clare’s Hospital. Schenectady, NY. November 2002.
  20. Stroke Risk Factor Subgroups, Vascular Events and Homocysteine: The Northern Manhattan Cohort Study. 11th European Stroke Conference. 2002. Geneva, Switzerland.
  21. Homocysteine Is Associated With Increased Vascular Morbidity And Mortality: The Northern Manhattan Prospective Cohort Study. 54th American Academy of Neurology Meeting April 2002. Denver, CO.
  22. Blood Levels Of Vitamin B12 And Folate Are Associated With Carotid Artery Plaque Thickness: The Northern Manhattan Stroke Study. 27th International Stroke Meeting. February 2002. San Antonio, TX
  23. Homocysteine Is Associated With Carotid Artery Plaque Thickness: The Northern Manhattan Stroke Study. Abstract. 53rd American Academy Of Neurology Meeting. 2001. Philadelphia, PA.
  24. Homocysteine and Cerebrovascular Disease. Neuro-Epidemiology Meeting. April 2001. G. Sergievski Center. Columbia University. New York, NY.
  25. Cerebral Venous Thrombosis. Grand Rounds. Albany Medical Center. May 2000. Albany, NY.


His broad experience in various conditions and kinds of treatment allowed him to master a very comprehensive and unique approach to the patient's evaluation and treatment. It taught him the necessity of being at the cutting edge of technology and to view a patient as a whole. Dr. Kaplan is always looking for new developments in medicine to implement in his practice in order to improve patients’ care and treatment outcomes. He is one of the few pain physicians and neurologists who pioneered ultrasound use for routine patient examination and interventional procedure guidance.


Dr. Kaplan’s is active in public arena. He is a Founder and a President of Connecting Link, Inc. a not for profit cultural and educational corporation with goals to promote different kinds of art and especially cultural exchange from Russia in the Capital Region. He served on the Business Committee of the Albany-Tula Alliance and on the Board of Trustees of the Russian American Cultural Center SPUTNIK.


Dr. Kaplan’s is licensed to practice medicine in New York State. He is fluent in English and Russian


Featured articles about Dr. Eugene Kaplan:

The Daily Gazette Article 9-14-07

The Daily Gazette Article 9-21-08

Dr. Kaplan personally authored or edited articles present on this website